Effect of Galcanezumab on Total Pain Burden in Patients Who Had Previously Not Benefited from Migraine Preventive Medication (CONQUER Trial): A Post Hoc Analysis
posted on 2022-08-05, 09:02authored byAdis journals on behalf of, Jessica Ailani, Jeffrey Scott Andrews, Antje Tockhorn-Heidenreich, Richard Wenzel, Mallikarjuna Rettiganti
The above video represents the opinions of the authors. For a full list of declarations, including funding and author disclosure statements, please see the full text online (see “read the peer-reviewed publication” opposite).